BUMPER SCIENCES
  • Home
  • Who we are
  • What we offer
    • Responsible Person (RP)
    • Formulation Studies
    • Project Management
    • Quality Assurance
    • Regulatory Affairs
    • Pre-clinical and Clinical
  • Meet the team
  • Contact Us
  • Plus
    • Home
    • Who we are
    • What we offer
      • Responsible Person (RP)
      • Formulation Studies
      • Project Management
      • Quality Assurance
      • Regulatory Affairs
      • Pre-clinical and Clinical
    • Meet the team
    • Contact Us
BUMPER SCIENCES
  • Home
  • Who we are
  • What we offer
    • Responsible Person (RP)
    • Formulation Studies
    • Project Management
    • Quality Assurance
    • Regulatory Affairs
    • Pre-clinical and Clinical
  • Meet the team
  • Contact Us

Project Management in Pharmaceutical Development

The aim of pharmaceutical development is to design a quality product and its manufacturing process to consistently deliver the intended performance of the product. (EU - Note for guidance on Development Pharmaceutics (CPMP/QWP/155/96)) 

With expertise in "hard-to-make" generics, we can support you with any pharmaceutical dosage form development

Working in close collaboration

  • We offer our expertise in the assessment and selection of new project
  • We analyze your needs and objectives to propose tailor-made development strategies 
  • You will receive regular and accurate progress reports on the project status
  •  You will always be consulted for strategic project decisions 
  • You can benefit of advices from independant experts of our consortium throughout the project
  • We support you in the resolution of technical issues experienced during the project
  • We stand up for your interests when dealing with subcontractors

Project management activities include

  • Establishement of development plan, budget and timelines.
  • Establishment of QTPP and RFQ.
  • Assessment of offer and recommandation of performance.
  • Screening of CMOs and technical visits. 
  • Establishment of development protocols (ICH Q8, Q9, Q10 and Q11). 
  • Rolling out of activities as per ICH Q1, Q2, Q3 and Q6.
  • Implementation of DP manufacturing process, scale up and validation.
  • Technology transferts and manufacturing troubleshooting. 
  • Follow up of action with CDMO 

  • Privacy Policy

BUMPER SCIENCES

Copyright © 2024 BUMPER SCIENCES - Tous droits réservés.

Ce site Web utilise les cookies.

Nous utilisons des cookies pour analyser le trafic du site Web et optimiser votre expérience du site. Lorsque vous acceptez notre utilisation des cookies, vos données seront agrégées avec toutes les autres données utilisateur.

RefuserAccepter